Cargando…
Mass Spectrometry-Based Glycoproteomics and Prostate Cancer
Aberrant glycosylation has long been known to be associated with cancer, since it is involved in key mechanisms such as tumour onset, development and progression. This review will focus on protein glycosylation studies in cells, tissue, urine and serum in the context of prostate cancer. A dedicated...
Autores principales: | Gabriele, Caterina, Prestagiacomo, Licia E., Cuda, Giovanni, Gaspari, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156230/ https://www.ncbi.nlm.nih.gov/pubmed/34069262 http://dx.doi.org/10.3390/ijms22105222 |
Ejemplares similares
-
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables
por: Gabriele, Caterina, et al.
Publicado: (2023) -
Data-Independent
Acquisition Mass Spectrometry of
EPS-Urine Coupled to Machine Learning: A Predictive Model for Prostate
Cancer
por: Prestagiacomo, Licia E., et al.
Publicado: (2023) -
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014) -
Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
por: Doud, Emma H., et al.
Publicado: (2023) -
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
por: Riley, Nicholas M., et al.
Publicado: (2020)